跳至主要内容
临床试验/ACTRN12615000576527
ACTRN12615000576527招募中未知

AustraLian Ovarian Cancer Assortment Trial (ALLOCATE) to perform comprehensive genetic screens on women diagnosed with ovarian cancer for potential therapeutic targets and drug response modifiers, and to facilitate the biological assortment and selection of suitable patients for clinical trials of approved and investigational-targeted therapies.

The University of Melbourne0 个研究点目标入组 60 人开始时间: 2015年6月3日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Women presenting at Royal Women's Hospital or the Peter MacCallum Cancer Centre with recurrent epithelial ovarian cancer (including peritoneal and fallopian tube cancers), regardless of histological subtype

排除标准

  • Exclusion from collection of fresh biopsy tissue if not deemed safe. Archival FFPE (paraffinised tumour sample) from previous surgery will be used in this case.

研究者

相似试验